Controversies and adverse reactions to beta-adrenergic agonists.
Sly
R M
RM
D000280:Administration, Inhalation; D000284:Administration, Oral; D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D000402:Airway Obstruction / Q000139:chemically induced*; D001249:Asthma / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D001548:Benzalkonium Compounds / Q000009:adverse effects; D016535:Bronchial Hyperreactivity / Q000139:chemically induced*; D005541:Forced Expiratory Volume; D006801:Humans; D017202:Myocardial Ischemia / Q000139:chemically induced*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013997:Time Factors
D000318:Adrenergic beta-Agonists; D001548:Benzalkonium Compounds